Export 49 results:
Author Title Type [ Year(Desc)]
Filters: Author is Rocha, S.  [Clear All Filters]
2008
Costa, E., Rocha, S., Rocha-Pereira, P., Castro, E., et al. (2008). Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under haemodialysis and recombinant human erythropoietin therapy. Blood Purification, 26(3), 267 - 273.
Costa, E., Rocha, S., Rocha-Pereira, P., Castro, E., et al. (2008). Changes in red blood cells membrane protein composition during hemodialysis procedure. Renal Failure, 30(10), 971 - 975.
Costa, E., Rocha, S., Rocha-Pereira, P., Castro, E., et al. (2008). Cross-talk between inflammation, coagulation/fibrinolysis and vascular access in hemodialysis patients. Journal of Vascular Access, 9(4), 248 - 253.
Costa, E., Rocha, S., Rocha-Pereira, P., Reis, F., et al. (2008). DMT1 (NRAMP2/DCT1) Genetic Variability and Resistance to Recombinant Human Erythropoietin Therapy in Chronic Kidney Disease Patients under Haemodialysis. Acta Haematologica, 120(1), 11 - 13.
Fernandes, J. C., Eaton, P., Nascimento, H., Belo, L., et al. (2008). Effects of chitooligosaccharides on human red blood cell morphology and membrane protein structure. Biomacromolecules, 9(12), 3346 - 3352.
Catarino, C., Rebelo, I., Belo, L., Rocha-Pereira, P., et al. (2008). Fetal lipoprotein changes in pre-eclampsia. Acta Obstetricia et Gynecologica Scandinavica, 87(6), 628 - 634.
Costa, E., Lima, M., Rocha, S., Rocha-Pereira, P., et al. (2008). IL-7 serum levels and lymphopenia in hemodialysis patients, non-responders to recombinant human erythropoietin therapy. Blood Cells, Molecules, and Diseases, 41(1), 134 - 135.
Costa, E., Lima, M., Alves, J. M., Rocha, S., et al. (2008). Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. Journal of Clinical Immunology, 28(3), 268 - 275.
Costa, E., Rocha, S., Rocha-Pereira, P., Nascimento, H., et al. (2008). Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. American Journal of Nephrology, 28(6), 935 - 940.
Rocha, S., Vitorino, R. M. P., Lemos-Amado, F. M., Castro, E. B., et al. (2008). Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells, Molecules, and Diseases, 41(1), 5 - 9.
Catarino, C., Rebelo, I., Belo, L., Rocha, S., et al. (2008). Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies. Thrombosis Research, 123(2), 219 - 224.
Costa, E., Pereira, B. J. G., Rocha-Pereira, P., Rocha, S., et al. (2008). Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. American Journal of Nephrology, 28(4), 677 - 683.
2009
Coimbra, S., Oliveira, H., Reis, F., Belo, L., et al. (2009). Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. Journal of Dermatological Science, 55(3), 202 - 204.
Rocha, S., Cardoso, I., Börner, H., Pereira, M. C., et al. (2009). Design and biological activity of β-sheet breaker peptide conjugates. Biochemical and Biophysical Research Communications, 380(2), 397 - 401.
Costa, E., Rocha, S., Rocha-Pereira, P., Reis, F., et al. (2009). Effect of hemodialysis procedure in prohepcidin serum levels in regular hemodialysis patients. Clinical Nephrology, 71(2), 233 - 235.
Paiva-Martins, F., Fernandes, J., Rocha, S., Nascimento, H., et al. (2009). Effects of olive oil polyphenols on erythrocyte oxidative damage. Molecular Nutrition and Food Research, 53(5), 609 - 616.
Catarino, C., Rebelo, I., Belo, L., Rocha-Pereira, P., et al. (2009). Erythrocyte changes in preeclampsia: Relationship between maternal and cord blood erythrocyte damage. Journal of Perinatal Medicine, 37(1), 19 - 27.
Catarino, C., Rebelo, I., Belo, L., Rocha, S., et al. (2009). Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy. Growth Factors, 27(6), 345 - 351.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@ibmc.up.pt | © copyright 2010 ibmc